Beta Bionics, Inc. (NASDAQ: BBNX) has priced a $150 million public offering this week just as its product story is acquiring more commercial torque: FDA clearance for the Mint™ patch pump, a planned U.S. launch in the first quarter of 2027, and a…
The diabetes-device sector is showing signs of a more interesting ailment for Wall Street: a shortage of skepticism. Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is pairing renewed financial discipline with product expansion, while Modular Medical, Inc. (NASDAQ: MODD) is taking its Pivot…